MOLN:SWX
Molecular Partners AG
CHF 3.07
arrow_upward
+0.33%(+0.0100) 1D
Oct 20, 3:49:03 PM GMT+2 · CHF
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MOLN...
Open
CHF 3.08
High
CHF 3.10
Low
CHF 3.05
Mkt. cap
123.95M
Avg. vol.
10.48K
Volume
3.65K
52-wk high
CHF 3.96
52-wk low
CHF 2.66
EPS
-CHF 1.37
Shares outstanding
40.37M
No. of employees
134
Open
CHF 3.08
High
CHF 3.10
Low
CHF 3.05
Mkt. cap
123.95M
Avg. vol.
10.48K
Volume
3.65K
52-wk high
CHF 3.96
52-wk low
CHF 2.66
EPS
-CHF 1.37
Shares outstanding
40.37M
No. of employees
134
News stories
From web sources and news partners
TradingView
·
41 minutes ago
The Dow Jones Index Opens 0.43% Higher
StoneX
·
1 hour ago
USD/JPY and Nasdaq Price Outlook: Key Levels to Watch
Breakingthenews.net
·
6 minutes ago
Dow up 400 points as earnings season heats up
Traders Union
·
1 hour ago
S&P 500 tests key support as traders weigh risk of deeper pullback
Profile
Molecular Partners AG is a clinical-stage biopharmaceutical company based in Zürich, Switzerland. The company is developing a new class of potent, specific and versatile small-protein therapies called DARPins, with potential clinical applications in a range of disease areas including oncology, immuno-oncology, ophthalmology, and infectious diseases. Molecular Partners currently has two DARPin molecules in clinical development, and a broad pipeline of molecules in preclinical development. Wikipedia
About Molecular Partners AG